Gregory Scott Duncan insider trades
Open-market stock purchases and sales by Gregory Scott Duncan, CHIEF EXECUTIVE OFFICER at Dogwood Therapeutics, Inc, from SEC Form 4 filings since Nov 2, 2020.
Get free alerts when Gregory Scott Duncan files a new trade →